FDA Hearing. What FDA Failed to Disclose: 1991, 2006.
AHRP Testimony presented by Vera Sharav, December 2006. PowerPoint slides (843 kb file).
Similar Posts
Newsweek Interviews FDA Chief of CDER about Needed Changes
FDA's Dr. Steven Galson, like his predecessor who now occupies a position in the Commissioner's office, demonstrates disconnectedness from reality, much like Nero who fiddled while Rome burned…
FDA Foot Dragging – Three Months After Expert Panel Urged "Black Box" Warnings for Antidepressants, No Action
FDA Foot Dragging – Three Months After Expert Panel Urged “Black Box” Warnings for Antidepressants, No Action Thu, 23 Dec 2004 Why is the FDA failing to enforce the "Black Box" warnings on SSRI antidepressant drug labels? When questioned by the NJ Star Ledger, Robert Temple, director of the FDA’s…
Congress to Probe NIH Conflict of Interest Policies
Congressional leaders have lost patience with the cat and mouse game being played by officials of the National Institutes of Health.
Facts Behind Merck’s Mandatory Vaccine Campaign to Help Pay forVioxx
American preteen girls have been designated to pay the price by exposing their bodies to risks of harm.
AHRP Testimony: Protections for Foster Children Enrolled in Clinical Trials Submitted to Cong.Ways & Means Hearing
 THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) https://ahrp.org 142 West End Ave. Suite 28P New York, NY 10023 Testimony by The Alliance for Human Research Protection Committee on Ways and Means Hearing on Protections for Foster Children Enrolled in Clinical Trials May 18, 2005 On March 10, 2004, The ALLIANCE…
Ecstasy- Long-lasting brain damage and may trigger Parkinson’s_BBC
Ecstasy- Long-lasting brain damage and may trigger Parkinson’s_BBC October 2, 2002 In 1989 Dr. George Ricaurte (Johsn Hopkins University) reported that MDMA (Ecstasy) the party drug used at all night dances (“raves”) caused neurotoxicity, long-lasting brain damage in non-human primates at doses similar to those ingested by humans. In the…